Prescription medicine
Dextrose and potassium chloride
Dextrose and potassium chloride is a prescription medicine with an FDA approval on record since 1979. FDA's NDC Directory lists it from 1 generic labeler.
- Generic listed
Check it at the source: the dextrose and potassium chloride FDA label on DailyMed (effective July 15, 2019, Baxter Healthcare Company); the NDA 17634 record on Drugs@FDA; every dextrose and potassium chloride label on DailyMed.
Highlights of the record
FDA label of July 15, 2019; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usagePotassium Chloride in Dextrose Injection is indicated as a source of water, electrolytes and calories.
Forms and strengths
- 5 g/100ml / 0.149 g/100ml
- 5 g/100ml / 0.15 g/100ml
- 75 mg/100ml / 5 g/100ml
- 150 mg/100ml / 5 g/100ml
Injection (solution); solution.
On the market
- Earliest approval on file
- February 1, 1979 Dextrose 5% And Potassium Chloride 0.224% In Plastic Container, Baxter Hlthcare; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 1 first September 10, 2020; 1 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 4 of which 1 under generic applications, 3 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 92,110 through July 30, 2026
What is dextrose and potassium chloride used for?
From the label: indications and usagePotassium Chloride in Dextrose Injection is indicated as a source of water, electrolytes and calories. Potassium Chloride in Dextrose Injection is indicated as a source of water, electrolytes and calories.
FDA pharmacologic class: Osmotic Laxative and Potassium Salt.
Source: FDA drug label (Potassium Chloride in Dextrose), Baxter Healthcare Company, effective July 15, 2019 (SPL set 45de5402-5e61-4bbd-8bbc-5e3392c9920e), via openFDA; the full label on DailyMed
Is there a generic for dextrose and potassium chloride?
The FDA approved the first generic dextrose and potassium chloride on September 10, 2020. 1 generic application is approved; 1 of it carries a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists dextrose and potassium chloride from 1 labeler under a generic (ANDA) application and from 3 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1979 earliest approval on file
- 2020 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What does the dextrose and potassium chloride label say about other medicines?
The dextrose and potassium chloride label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Digoxin | warnings and precautions | • with severe renal impairment, acute dehydration, extensive tissue injury or burns, and certain cardiac disorders such as congestive heart failure or AV block (especially if they receive digoxin). |
| Thiamine | warnings and precautions | Thiamine deficiency and fluid retention may also develop. To prevent these complications, monitor severely undernourished patients and slowly increasing nutrient intake. |
Check dextrose and potassium chloride against other medicines
Source: FDA drug label (Potassium Chloride in Dextrose), Baxter Healthcare Company, effective July 15, 2019 (SPL set 45de5402-5e61-4bbd-8bbc-5e3392c9920e), via openFDA; the full label on DailyMed
What do FAERS reports show for dextrose and potassium chloride?
The FDA Adverse Event Reporting System holds 92,110 reports that list dextrose and potassium chloride among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 13,521 are coded as a death and 42,525 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other osmotic laxatives
- the pharmacologic class, with prices and generics
- Dextrose and potassium chloride side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other